Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

93 papers

Active filtersClassification:Supporting

Showing 49-60 of total 93 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Traumatic Brain Injury: Multi-Omics Insights into Brain Aging, Neurodegeneration, and Precision Therapeutics.

Shafie A; Ashour AA; Alhujaily MM; Anjum F; Akhtar F; Hassan MI

Jan 1, 2026

2026PubMedSupporting evidence

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Sekita A; Sprügel MI; Balk S; Haupenthal D; Engelhorn T; Schmidt MA; Doerfler A; Oberstein TJ; Maler JM; Kornhuber J; Lewczuk P; Rothhammer V; Schwab S; Kuramatsu JB; Sembill JA

Jan 1, 2026Alzheimer's & dementia (Amsterdam, Netherlands)

2025CrossrefSupporting evidence41 citations

Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration

Elise A. Kellett; Adekunle T. Bademosi; Adam K. Walker

May 8, 2025Molecular Neurodegeneration

2024OpenAlexSupporting evidence0 citations

Vascular Aging Markers and Blood Biomarkers of Neurodegeneration

Vanessa A. Guzman; Maliyah Panton; Salwa Rahman; Antonio J. Spagnolo Allende; Mitchell S.V. Elkind; Tatjana Rundek; Randolph S. Marshall; Stephanie Cosentino; Jennifer J. Manly; José Gutierrez

Dec 1, 2024Alzheimer s & Dementia

2023OpenAlexSupporting evidence1,644 citations

Role of neuroinflammation in neurodegeneration development

Weifeng Zhang; Dan Xiao; Qinwen Mao; Haibin Xia

Jul 12, 2023Signal Transduction and Targeted Therapy

2022OpenAlexSupporting evidence507 citations

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Priyanka Rawat; Ujala Sehar; Jasbir Bisht; Ashley Selman; John Culberson; P. Hemachandra Reddy

Oct 25, 2022International Journal of Molecular Sciences

2021CrossrefSupporting evidence3 citations

Presence of endogenous Aβ in plasma of patient with Alzheimer’s disease differentiates Aβ oligomerization tendencies caused by synthetic Aβ

Youngki Choi; Ji Sun Yu; Yechan Joh; Sungmin Kang; Young Chul Youn; Seong Soo An; Sangyun Kim

Dec 1, 2021Alzheimer's & Dementia

2021CrossrefSupporting evidence1 citations

High precision plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio detects early amyloid deposition in non‐demented elderly adults

Dai Shi; Lei Zhang; Tengfei Guo

Dec 1, 2021Alzheimer's & Dementia

2021CrossrefSupporting evidence276 citations

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Henry Querfurth; Han-Kyu Lee

Jul 2, 2021Molecular Neurodegeneration

2021OpenAlexSupporting evidence121 citations

The Evolution of Neurofilament Light Chain in Multiple Sclerosis

Carolina Ferreira‐Atuesta; Saúl Reyes; Gavin Giovanonni; Sharmilee Gnanapavan

Apr 6, 2021Frontiers in Neuroscience

2021OpenAlexSupporting evidence361 citations

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

Joel Simrén; Antoine Leuzy; Thomas K. Karikari; Abdul Hye; Andréa Lessa Benedet; Juan Lantero‐Rodriguez; Niklas Mattsson; Michael Schöll; Patrizia Mecocci; Bruno Vellas; Magda Tsolaki; Iwona Kłoszewska; Hilkka Soininen; Simon Lovestone; Dag Aarsland; Oskar Hansson; Pedro Rosa‐Neto; Eric Westman; Kaj Blennow; Henrik Zetterberg; Nicholas J. Ashton

Jan 25, 2021Alzheimer s & Dementia

2020OpenAlexSupporting evidence143 citations

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway

Nóra Török; Masaru Tanaka; László Vécsei

Dec 8, 2020International Journal of Molecular Sciences